Navigation Links
Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food for Local Families
Date:6/27/2011

EXTON, Pa., June 27, 2011 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has successfully completed a campaign to collect 8,792 pounds of food from its employees, more than 5 times as much as it collected last year. With approximately 200 employees at Morphotek, this number equates to over 40 pounds of food donated per employee. The food will be donated to local needy families through collaboration with Philabundance, the area's largest food bank and hunger relief organization.

(Photo: http://photos.prnewswire.com/prnh/20110627/PH25841-a)

(Photo: http://photos.prnewswire.com/prnh/20110627/PH25841-b)

(Photo: http://photos.prnewswire.com/prnh/20110627/PH25841-c)

(Photo: http://photos.prnewswire.com/prnh/20110627/PH25841-d)

Last year, Morphotek employees collected over 1750 pounds of food; this year's substantial increase reflects both increased awareness and commitment on the part of Morphotek to help address the challenges so many area families currently face in meeting basic necessities in difficult economic times.

Morphotek's Chief Medical Officer, Dr. Martin D. Phillips, is also a Member of the Board of Directors of Philabundance.  In response to this year's results, Dr. Phillips stated, "This is a very nice demonstration of the commitment of the employees of both Morphotek and Philabundance to the welfare of our neighbors in the Delaware Valley.  It exemplifies our human health care credo, which includes not only support of our communities and patients in developing medicines, but also to become personally involved in understanding their needs."

Philabundance reduces hunger and food insecurity in the Delaware Valley by providing food access to people in need in partnership with organizations and individuals. Philabundance provides a full plate of services to close to 500 member agencies in 9 counties, who serve approximately 65,000 people per week at an aggregate cost of 50 cents per meal. There are more than 900,000 people in the Delaware Valley who are at risk for chronic hunger and malnutrition. In 2010, Philabundance distributed 21 million pounds of food. For more information about Philabundance, visit www.philabundance.org, or call 215-339-0900.

About MorphotekMorphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology.  The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications.  The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease.  For more information, please visit www.morphotek.com.

About Eisai Inc.Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales).  The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business.  Eisai's areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care.  The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.  

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina.  The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs.  For more information about Eisai, please visit www.eisai.com/us. Contacts:Media Inquiries

Investor InquiriesTerry Cushmore

Rod Dausch Morphotek, Inc.

Morphotek, Inc. 610-423-6197

610-423-6111 tcushmore@morphotek.com

Dausch@morphotek.com
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Life Technologies Employees Give Back to Their Communities During Eighth Annual Global Volunteer Day
2. Asymchem Laboratories Hires Three New Employees: Guojie Xu, Pingzhong Huang, and Xiaojun Huang
3. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
4. BNBI Employees Donate 1,000 Backpacks to Frederick County School Children
5. Nanoparticles improve solar collection efficiency
6. BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
7. Cord Blood America Announces Second Supply Agreement to Provide Placenta, Umbilical Cord Collection Services to Major Tissue Bank
8. A new twist for nanopillar light collectors
9. Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist
10. Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions
11. Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eutilex Co. Ltd. today announced that ... Series A financing. This financing round included participation from ... SNU Bio Angel. This new funding brings the total ... $27.7M) since its founding in 2015. ... and commercialization of its immuno-oncology programs, expand its R&D ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
(Date:12/7/2016)... McLean, VA (PRWEB) , ... December 07, 2016 ... ... peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced ... Further refinement in defining the optimal patient population and timing of blood sampling ...
(Date:12/7/2016)... LANSING, Mich. , Dec. 7, 2016 ... it has named Dr. Dan Kephart as ... the company. Kephart will assume his responsibilities at Neogen ... research and development director for the agribusiness unit of ... food safety development at Life Technologies. His extensive industry ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/17/2016)... OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it has ... using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer storage ... ... ... Setting up ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
Breaking Biology News(10 mins):